High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course

Post time The day before yesterday 22:06

journal：JCO Oncology Practice

Authors：Darragh F. O'Donoghue; Huong L. Truong; Heidi D. Finnes; Jennifer S. McDonald; Heather P. May; Stephen M. Ansell; N. Nora Bennani; Thomas M. Habermann; David J. Inwards; Patrick B. Johnston; Arushi Khurana; Yi Lin; Ivana N. Micallef; Grzegorz S. Nowakowski; Jonas Paludo; Luis F. Porrata; Gita Thanarajasingam; Carrie A. Thompson; Jose C. Villasboas; Yucai Wang; Thomas E. Witzig; Nelson Leung

Published date：2022-12-

DOI：10.1200/op.22.00182

PDF link：https://ascopubs.org/doi/pdfdirect/10.1200/OP.22.00182

Article link：https://doi.org/10.1200/op.22.00182

Article Source：American Society of Clinical Oncology (ASCO)。

Remark：

Post time The day before yesterday 22:12

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Other] High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course